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exploring cancer patients’ perceptions of taking
part in a trial of acupressure wristbands
John Gareth Hughes1*, Wanda Russell2, Matthew Breckons3, Janet Richardson4, Mari Lloyd-Williams5
and Alex Molassiotis2Abstract
Background: Nested qualitative studies within clinical trials provide data on patients’ experiences of receiving trial
interventions and can inform and improve trial designs. The present study explored patients’ experiences of
participating in a randomised controlled trial of acupressure wristbands for chemotherapy related nausea.
Methods: A randomised three-group sham-controlled trial was carried out to evaluate the effectiveness of
acupressure wristbands in the management of chemotherapy-related nausea. A convenience sample of 26 patients
volunteered to participate in a qualitative study to explore their experiences of using acupressure wristbands, and
taking part in the clinical trial. Participants were recruited from each of the three UK geographical sites from which
the trial was conducted: Manchester, Liverpool and Plymouth. In-depth semi-structured interviews were conducted
with the participants in their own homes or other location convenient for participating patients. Interviews were
audio-taped, transcribed verbatim and analysed using Framework methodology.
Results: The main motivational factors influencing participants to take part in the trial were a desire to ‘give
something back’ and limit their own experience of nausea. Participants were largely satisfied with the organisation
and running of the acupressure wristband trial. Many participants experienced positive outcomes as a result of
taking part in the trial. Lapses in memory, or poor health as a result of their chemotherapy treatment, led to some
participants failing to complete trial paperwork on designated days. Two sham wristband participants reported
wearing the bands inappropriately resulting in pressure being applied to the acupoint. Almost all of the participants
interviewed had only experienced mild nausea or vomiting during the trial. Participants were pragmatic on the
extent to which the wristbands were responsible for this lack of nausea and vomiting during the trial. However,
many participants, including some patients receiving sham acupressure, believed the wristbands to have had a
positive impact on their nausea and vomiting; there was a perception that the wristbands were, at least in part,
responsible for the lack of nausea and vomiting they had experienced.
Conclusions: Participants perceive acupressure wristbands as reducing the level of nausea and vomiting
experienced during chemotherapy treatment. Reports that some participants wore wristbands inappropriately, and/
or delayed completion of trial paperwork could represent confounding variables and have implications for the trial
results, and the design of clinical trials within the field of cancer.
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Qualitative research has been used extensively to explore
patients’ experiences of complementary and alternative
medicine (CAM) including acupuncture [1-6]. Findings
suggest that acupuncture treatment frequently produces
benefits beyond the alleviation of the patients’ presenting
condition. These co-benefits include improvements in
physical/mental health, emotional well-being and changes
in personal identity and lifestyle, and can result in patients
‘feeling normal again’ and ‘regaining their lives.’ There is
however a lack of research which has explored the experi-
ences of users of acupressure or acupressure wristbands.
Furthermore, although the concept of ‘nested qualitative
studies’ in the context of randomised clinical trials (RCTs)
is now commonplace in studies evaluating conventional
treatments, this is notably absent from CAM studies.
Qualitative studies nested within an RCT can inform
and improve trial designs. Published research has explored
aspects of trial participation, including recruitment, lay
understandings of randomisation, informed consent, treat-
ment compliance and retention to the trial [7-11].
Additionally, they can provide valuable data on patients’
experiences of receiving trial interventions and their per-
ceptions of treatment effects (which may differ from those
of patients receiving the same treatment within clinical
practice). Trial context will have an impact on how treat-
ment is perceived; participants in a clinical trial will have
to read patient information sheets, be randomised to re-
ceive an active or placebo intervention, and complete trial
paperwork throughout the length of their participation.
A search of the literature reveals a limited number of
nested qualitative studies exploring patients’ experiences
of participating in trials of CAM interventions. These
studies have been nested within clinical trials of acupunc-
ture for medically unexplained symptoms, osteoarthritis,
migraine, irritable bowel syndrome and stress [12-16]. All
explored patients’ experiences of receiving treatment
within the context of a clinical trial, however two addition-
ally explored patients’ experiences of taking part in the
trial itself [14,16]. Paterson et al. conducted a study within
a randomised sham controlled trial of traditional Chinese
acupuncture for patients with migraine [16]. Patients in
the Paterson et al. study were found to have actively
‘played their part’ in the trial, taking on research roles that
differed from their usual role as patients. The authors sug-
gested that the participation in the trial resulted in
changes to the normal expectations and behaviour and
this changed how the intervention was experienced.
This paper reports on a qualitative study that was nested
within a randomised, single-blind, sham-controlled trial of
acupressure wristbands for chemotherapy related nausea.
The research aimed to explore their experiences of using
acupressure wristbands and taking part in a randomised
controlled trial.Methodology
This qualitative study was nested within a RCT of acu-
pressure wristbands for chemotherapy related nausea [17].
The study was carried out at three geographical sites
within the UK: Manchester, Liverpool, Plymouth and the
surrounding regions. Interviews took place between
September 2010 and March 2011. Ethical approval for
both the acupressure wristband trial and the nested quali-
tative study were obtained from Central Manchester Re-
search Ethics Committee [REC reference number: 08/
H1008/2]. The acupressure wristband trial is registered
with the ISRCTN register [number ISRCTN87604299].
The trial
A randomised, single-blind, sham-controlled, three armed
trial was carried out to evaluate the effectiveness of acu-
pressure wristbands for chemotherapy-related nausea [17].
500 patients with heterogeneous cancer diagnoses receiv-
ing low, moderate and highly emetogenic chemotherapy
were included in the trial. Trial arms consisted of
standardised antiemetics plus either acupressure wrist-
bands, sham acupressure wristbands or antiemetics alone.
In the true acupressure group patients were provided with
a pair of wristbands. These bands are elastic wristbands
with a 1 cm protruding round plastic button, which
presses on the P6 acu-point. The sham wristband group
received identically appearing wristbands, with the only
difference being that they had a flat button in place of the
protruding button, thus exerting no pressure on the P6
acu-point. Those allocated to receive wristbands were
instructed to wear them throughout the first 7 days of
4 cycles of chemotherapy. Primary outcome assessment
was the Rhodes Index for Nausea and Vomiting [18]
which was carried out daily for 7 days per chemotherapy
cycle. Additional assessment tools which were completed
during each cycle of chemotherapy included the MASCC
Antiemesis Tool (acute and delayed) [19], hospital anxiety
and depression (HAD) scale [20], EQ-5D Utility scale [21]
and the FACT-G quality of life scale [22]. At baseline par-
ticipants also completed measures of nausea expectation,
and expectations from using acupressure wristbands. An
economic evaluation was carried out based on drug and
health service utilisation from the perspective of the
health and social care provider.
Sample
A convenience sample of 26 patients volunteered to par-
ticipate in the qualitative study to explore their experi-
ences of using acupressure wristbands, and taking part
in the clinical trial. Participants were recruited from each
of the three geographical sites from which the trial was
conducted. Nine were recruited from Manchester, 9 from
Liverpool, and 8 from Plymouth and the surrounding re-
gions. Ten of the participating patients had received true
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receiving no acupressure. Sixteen participants were diag-
nosed with breast cancer, 6 colorectal, 3 lung, and 1 Non
Hodgkin’s Lymphoma. Nine of the sample were classified
as having received chemotherapy of high emetogenic po-
tential, 12 moderate, and 5 low. Participants had a diverse
range of expectations and demographics. The age range of
the participants was 35–79 (mean 55, median 55), 7 were
male and 19 female. Expectation of how much nausea par-
ticipants expected to experience during their chemother-
apy treatment ranged from 0–10 (mean 5.8, median 5),
with 0 being ‘not at all’ and 10 being ‘very frequently.’
While participants’ belief that acupressure wristbands
would help manage their sickness ranged from 2 to 10
(mean 6.9, median 6), with 0 being ‘not at all’ and 10 being
‘will help me a lot.’
Methods
A constructivist epistemological approach was adopted
for the qualitative study based on the belief that, “data
do not provide a window on reality. Rather, the ‘discov-
ered’ reality arises from the interactive process and its
temporal, cultural, and structural contexts” [23]. Invita-
tions to participate in a qualitative interview were posted
to all patients who completed their participation in the
clinical trial of acupressure wristbands, or withdrawal
from the trial, between February 2010 and December
2010. Interested patients returned a contact sheet to
members of the research team who subsequently tele-
phoned them, discussed the qualitative study, obtained
verbal consent, and arranged a face-to-face interview. All
patients willing to participate were interviewed. All inter-
views were conducted within 3 months of patient's com-
pleting, or withdrawing, from the trial. In-depth semi-
structured interviews were conducted with the partici-
pants in their own homes or other location convenient for
participating patients. The interviews were preceded by
obtaining written consent. Interviews were conducted by
three members of the research team (JH, WR, MB) and
were directed by a topic guide. The topic guide was
devised by the researchers based on previous research ex-
ploring experiences of receiving acupuncture or participat-
ing in clinical trials. The topic guide incorporated a series
of open ended questions designed to explore participants’
experiences of taking part in a trial of acupressure wrist-
bands, and for those allocated to receive wristbands, their
experiences of using them. Topic guides were updated
throughout the study to incorporate emerging themes. In-
terviews were audio-taped and transcribed verbatim. In-
terviews lasted for between 30 and 70 min. Transcripts
were analysed thematically using Framework analysis; a
manual, matrix method, which facilitates thematic and
cross-case interpretation [24,25]. Framework analysis
was the chosen method for data analysis as this providesa transparent five step approach and provides a clear
process for cross-referencing and comparing themes
across participants. Analysis proceeded in five stages:
 Familiarization. Transcripts were read and re-read
by members of the research team to familiarize and
immerse in the data.
 Identification of the thematic framework. Key issues,
concepts and themes arising from the data were
identified by the research team, and grouped
thematically to construct a conceptual framework.
 Indexing. Two of the research team (JH, WR)
independently applied the thematic framework to
the same transcript to explore any differences in
application. The thematic framework was then
applied systematically to all the data (JH).
 Charting. Thematic matrices were constructed for
all identified categories/subcategories to further
summarise and synthesise the indexed data (JH).
Thematic matrices consisted of tables of well-
defined units of text, with identified categories and
subcategories along the x axis and individual
participants along the y axis.
 Detection, categorization and classification. The
original research questions were reconsidered, and
the charts examined in order to define concepts,
map the range and nature of phenomena, find any
associations and provide explanations (JH).
Results
Major categories and sub-categories describing partici-
pants’ experiences of taking part in the trial and wearing
the acupressure wristbands emerged from the data:-
views on complementary therapies; deciding to partici-
pate; experiences during trial participation; wearing
wristbands; perceptions of wristband effects and placebos
in research. The category placebos in research will be ex-
plored in a separate publication as the category was not
linked to participants’ experiences of receiving the inter-
vention or participating in the clinical trial.
Views on complementary therapies
Most participants had only limited personal experience
of receiving complementary therapy treatments prior to
taking part in the trial of acupressure wristbands. Des-
pite limited personal use of complementary therapies, a
number of participants expressed an awareness of the
current lack of unequivocal research into the evidence
base underpinning many complementary treatments. Par-
ticipants frequently described themselves as ‘open minded’
with regards to complementary therapies and their effect-
iveness. Interviewees often cited the successful treatment
of family/friends, or the long history of some of the treat-
ments, with comments such as ‘it’s been around for years,
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mentary therapies were also perceived as being ‘natural’,
‘safe’ treatments associated with fewer side effects than
conventional medicine. Interestingly, some participants in-
dicated that their involvement in the trial had altered their
perception of complementary therapies. Typically, their
personal experiences of using the acupressure wristbands
resulted in them having a greater conviction in the bene-
fits of complementary therapies.
“Because I mean you do realise that you know if you
take medications you erm… yes if you take the drugs
and that basically, you know you take one drug for
one thing and then you probably got to take another
one to counter act that one, whereas the erm… the
more natural remedies, you know I don’t think is
probably quite so bad.” [48 year old female receiving
high emetogenic chemotherapy allocated to receive no
wristbands during the trial].
“The complementary therapies are holistic and they’re
actually…a lot of the things they’re using have been,
you know, handed down for generations.” [58 year old
female receiving low emetogenic chemotherapy,
allocated to receive sham wristbands].
Most participants saw the role of complementary therap-
ies as being in combination with conventional medicine.
Indeed some participants indicated that they would only
be willing to receive complementary therapies if they were
provided within the National Health Service (NHS), or if
they were advised to use them by a treating conventional
healthcare practitioner. Irrespective of whether participants
had any previous experience of using complementary ther-
apies, they were near unanimous in the importance which
they placed on research into the effectiveness of comple-
mentary treatments. There was a view amongst some, that
there should be a greater integration of complementary
therapies and conventional therapies provided within the
NHS, but that this increasing integration should be under-
pinned by an emerging evidence base.
“I think it’s very important [research into
complementary therapies]. Yes. Because I see
complementary medicine as being non-invasive being,
as being an aid to conventional medicines, or an add-
on to conventional medicines. Yes.” [57 year old
female receiving high emetogenic chemotherapy,
allocated to receive sham wristbands].
“It is something in general complementary medicine
is something that are never taken seriously, I don’t
think, but they should be because you know you hear
some remarkable stories about them, so I think theyshould be up there with all the drug research and
everything yes, definitely.” [59 year old female
receiving moderate emetogenic chemotherapy,
allocated to receive true wristbands].
Deciding to participate
Interested patients were provided with details of the
study and what participation would involve and were re-
quired to consider participation for at least 24 hours be-
fore consenting. While many discussed participation
with their clinical team or significant others, for the ma-
jority of participants the decision to take part in the trial
appeared to have been made almost immediately, with
phrases such as ‘I didn’t hesitate’ being common.
When asked about their reasons for participating in
the clinical trial, participants identified a range of factors
influencing their decision. Undoubtedly the main motiv-
ational factor influencing participants was a desire to
‘give something back’. There was an appreciation that
the willingness of previous patients to engage in research
had improved their own cancer treatment, and that for
cancer treatments to improve in the future current pa-
tients would need to take part in research studies. In
particular, it was the altruistic act of attempting to im-
prove the care of future cancer patients which motivated
participants to assist in evaluating if acupressure wrist-
bands were effective for chemotherapy related nausea.
“My reasons were as I’d had various treatments
obviously associated with the diagnosis I’d had earlier
that year it was partly that each time I had treatment
I did reflect on people that had gone before me who
from their experience and their participation in
possible research that that perhaps made things easier
for me in my experience. So it was a small way of
trying to help for the future. That was kind of in my
head, that I just wanted to try and be part of this and
hopefully that would help people like me in the
future.” [55 year old female receiving moderate
emetogenic chemotherapy, allocated to receive no
wristbands].
“Just to assist in any way I could with any product or
any medicine or anything that might help people in
the future. That was basically it.” [59 year old female
receiving moderate emetogenic chemotherapy,
allocated to receive true wristbands].
Participants were aware that their chemotherapy treat-
ment was associated with a number of side-effects, in-
cluding nausea and vomiting. Participation in the trial
did not affect antiemetic prescribing as randomization to
receive wristbands was offered in addition. A desire to
limit their own experience of nausea and vomiting
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motivational factor for almost all participants.
“Because I could see all the list of things that you
have, the after effects, you get tummy upsets and stuff
like that. Then I thought well, if that’s going to help
me I don’t want to keep being sick, if it does help me
I’ll have a go.” [79 year old male receiving low
emetogenic chemotherapy, allocated to receive true
wristbands].
“One of the biggest concerns I had when I was
approaching having chemotherapy was purely based
on what you hear from other people, and nausea kept
coming up all the time. So, again, I thought well
maybe there would be some benefits as well for me,
because obviously that’s what the research was about.”
[55 year old female receiving moderate emetogenic
chemotherapy, allocated to receive no wristbands].
A minority of participants identified additional motiv-
ational factors. These included the lack of any perceived
risk of adverse effects from taking part in the trial, and a
preconceived belief in the effectiveness and value of
complementary therapies. For participants attending a
hospital in one of the study sites, the dialogue with their
medical consultant was also identified as influencing the
decision of some patients to participate. Specifically, in-
formation regarding additional funding which the hos-
pital itself would receive from patients participating in
clinical trials was an extra motivational factor.
“It was very clear wasn’t it from the beginning that
there wasn’t going to be any adverse side effects from it,
because I don’t honestly think I would have done it if
there were given the fact that I was going to be, have so
many side effects from the chemotherapy you just
wouldn’t want to add any more adverse side effects to
the ones you were already having at the minute so, yes”
[44 year old female receiving high emetogenic
chemotherapy, allocated to receive true wristbands].
“Yes he was very supportive [hospital consultant] and
he did ask me every time I went for an appointment
how it was going. And he explained as well that in
addition to finding out whether it worked it also
provided additional funding into the team, so that just
reinforced that I wanted to do it really.” [38 year old
female receiving high emetogenic chemotherapy,
allocated to receive sham wristbands].
Experiences during trial participation
Only a couple of participants had any previous experience
of taking part in a research study prior to the acupressurewristband trial. Participants indicated they felt they had a
good understanding of the study before providing their
written consent, with many recounting the written and
verbal information they had received before consenting.
Part of this process was information on the randomisation
process, and participants were pragmatic in their percep-
tion of randomisation, exemplified by one female partici-
pant who commented ‘you are either going to be lucky if
you get the wristbands and it might help, you are unlucky
you don't get anything and you just carry on as you would
do if you wasn’t on the trial.’ However, despite this ap-
proach many allocated to treatment as normal still indi-
cated they felt ‘disappointed’ at not receiving wristbands.
Many participants expressed initially feeling daunted
upon receiving the packs of outcome measures to be
completed during the trial. As one female participant
stated, ‘I thought oh crumbs [laughter]. I thought oh
God every day.’ However, these feelings typically sub-
sided once participants familiarised themselves with the
outcome forms, and realised that forms were extensively
duplicated. Participants generally felt included question-
naires were easy to follow, with comments like ‘pretty
straight forward’ being common. Although perceived as
being easy to complete a few participants felt they were
a little onerous, making comments such as ‘they were
perhaps, perhaps a little bit too lengthy maybe.’ Some in-
dicated that they failed to complete all the paperwork on
the designated days. In particular lapses in memory, or
poor health as a result of their chemotherapy treatment,
led to forms sometimes being completed retrospectively.
In some instances this could involve forms being com-
pleted up to one week after the date they were supposed
to be completed on.
“I think if you start off every night you are doing it, or
whatever it is, I will hold my hands up and say, then
you kind of, oh I didn’t do it that night, I didn’t do it
that night, and then you say I have got to do them
forms, and you would rely then on memory.
Obviously it weren’t going back weeks, but instead of
that, you would start like a bull at a gate every night
yes, but you would quickly change to, oh I will blast
this all in one go. Probably not right, but that’s being
honest with you, then that is what happened and I
would think most people do the same.” [41 year old
female receiving high emetogenic chemotherapy,
allocated to receive no wristbands].
“Some of the days when I was really, really poorly
with the chemo I couldn't even get out of bed to even
fill it in I’ll be honest, but I knew each day how bad I
was, how sick I was. So, you know, was able to fill it
in accurately because I knew that at the beginning I
was so poorly and so sick and by the end of it you are
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come round and I was out of bed I filled it in.”
[49 year old female receiving moderate emetogenic
chemotherapy, allocated to receive no wristbands].
Participants expressed satisfaction with the organisa-
tion and running of the acupressure wristband trial. A
number felt that they had experienced positive outcomes
as a result of taking part in the trial and this linked to
their reports of motivations for taking part. Most fre-
quent was a sense of wellbeing as a result of feeling they
had completed an altruistic act and helped others. Add-
itionally, some felt that the process of completing the
trial outcome measures had been of benefit to them.
Specifically, that it provided them with some control, at
a time when most felt a lack of control over their cancer
experience; or that they gained benefit from being able
to reflect on how their symptoms had improved during
previous cycles of chemotherapy. In contrast a small num-
ber of participants indicated they had experienced some
negative effects from completing the outcome measures,
chiefly that reading and rating their level of nausea and
vomiting at a time when they were feeling nauseous had
at times worsened their experience.
“I think taking part in the trial is quite, it makes you
feel better actually because it is a useful tool and it’s
going to be of use for other people in the future……
Yes because it makes you feel better doesn’t it if you
feel you are contributing something.” [53 year old
male receiving moderate emetogenic chemotherapy,
allocated to receive no wristbands].
“I just completed the forms as requested and it was
no hassle at all. And actually it helped because it was
something positive to do, on certain days and ticking
the boxes and all that sort of thing, I felt because I
think part of having cancer is you lose control, and I
am quite, the sort of person that likes to be in control
and this is enabling me a little bit of control back, so
that part I quite enjoyed actually.” [55 year old female
receiving high emetogenic chemotherapy, allocated to
receive sham wristbands].
Wearing wristbands
Those participants who were allocated to receive either
true or sham wristbands during the trial were asked
about their experiences of using them. Almost all partic-
ipants interviewed appear to have worn the wristbands
as instructed, keeping them on for 7 days following
chemotherapy and only removing them when washing
or bathing. Indeed some participants continued using the
wristbands after the 7 day period, while many also contin-
ued to wear the wristbands after the 4 chemotherapycycles they participated in the trial. Participants were
asked to demonstrate how they wore the bands, with all
but two of those interviewed apparently wearing the wrist-
bands in the correct position during the trial. The two
participants who were found to have worn the bands in-
appropriately had both been allocated to receive sham
wristbands. In one instance the participant wore the wrist-
bands inside out (meaning slight pressure would have
been applied to the P6 acupoint); while in the other the
participant indicated that they had manually applied pres-
sure to acupoint P6 during the trial.
Participants reported that they had not experienced
any restrictions from wearing the wristbands in terms of
everyday activities, other than washing and bathing. As
one female participant commented, ‘I don’t have many
household chores, but no not at all, not at all. I just, take
them off when I have a bath or a shower, other than that
no they are not intrusive at all.’ For most participants
the wristbands were seen as comfortable to wear. Al-
though a few participants reported that they had experi-
enced minor irritations, such as the wristbands feeling
tight or painful, or their wrists becoming itchy. Reported
adverse side effects were generally deemed minor and
acceptable.
“I find sometimes my, it gets, my skin gets quite red,
and they rub.” [35 year old female receiving moderate
emetogenic chemotherapy, allocated to receive sham
wristbands].
“I did find the bobble that went into your arm painful
a few times.” [56 year old female receiving high
emetogenic chemotherapy, allocated to receive true
wristbands].
A number of participants highlighted the fact that they
had been questioned by other people about wearing the
acupressure wristbands. For many, the curiosity of others
had little influence on band use, as one male participant
commented, ‘if they don’t like it, that’s their problem…..
didn’t influence me whatsoever.’ However, a few revealed
that they had inhibitions about wearing them in the com-
pany of others; or had received negative responses from
others to their wearing of the wristbands. When asked
about this, some compared the minor impact of wearing
acupressure wristbands to the more outwardly visible con-
sequences of their conventional medical treatment, such
as loss of hair or having surgical pointers displayed on
their body.
“It’s a silly point but they are there all the time, so you
do sort of start pulling your sleeves down because you
don’t want people to see them, you know it looks
rather strange walking round with two wristbands
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you know you chat to people and people ask you, and
so, I would just tell people but if you went for a meal
or if you were out somewhere socially where people
didn’t know you, you would feel slightly embarrassed.
These two bands, that look as though you should be
in the gym.” [57 year old female receiving high
emetogenic chemotherapy, allocated to receive sham
wristbands].
“They didn’t take any notice of it whatsoever it wasn’t
that obtrusive, I am more self conscious about the
hole in my throat, than I were of any bloody arm
bands. So I usually had a coat on anyway and nobody
would outside hardly seen them.” [66 year old male
receiving moderate emetogenic chemotherapy,
allocated to receive true wristbands].
Perceptions of wristband effects
Almost all participants interviewed had only experienced
mild nausea or vomiting during the trial. They were
pragmatic about the extent to which the wristbands were
responsible for this lack of nausea and vomiting during
the trial. They reported that there could be a number of
other reasons, including their antiemetic medication,
basic constitution, or just luck! However, many partici-
pants, including some patients receiving sham acupres-
sure, believed the wristbands to have had a positive
impact on their nausea and vomiting; there was a per-
ception that the wristbands were, at least in part, re-
sponsible for the lack of nausea and vomiting they had
experienced. For some this was due to their experiences
during the trial, such as participants who noticed their
nausea was greater if they didn’t have the wristbands on,
or if they were wearing the wristbands in an incorrect
position. The wristbands were not seen as being any
more, or less effective, at different times of day, or at dif-
ferent points in the participants’ chemotherapy treat-
ment. There were no additional benefits reported from
wearing the wristbands beyond the potential alleviation
of nausea and vomiting.
“Until the trial is complete you can’t really say
whether it helped you or not can you…. I wore them,
yes I wore them each time I had treatment yes. And
erm yes I feel as though I benefited from them, and I
think I possibly would have been more sick than what
I was. I felt the bands did help in that respect. Yes.”
[55 year old female receiving moderate emetogenic
chemotherapy, allocated to receive true wristbands].
“I would be feeling a bit sick and I would think
‘goodness me, why am I feeling so sick’ and then I
would put them on and it would improve and one dayI was feeling sick with them on, but they weren’t in
the right place (laughs) I was looking at them and
they weren’t in the right place, so there is a reason
you know, this is why I have got such belief in them
now.” [56 year old female receiving high emetogenic
chemotherapy, allocated to receive true wristbands].
Irrespective of perceptions of effectiveness, almost all
participants indicated that they would recommend the
wristbands to other chemotherapy patients, or to patients
experiencing nausea and vomiting due to other causes.
This related to the fact that, irrespective of whether the
wristbands were of benefit for nausea and vomiting, they
were not associated with having any negative or adverse
effects.
“There isn’t a reason not to wear them. Personally yes.
So, yes I would recommend them yes.” [38 year old
male receiving moderate emetogenic chemotherapy,
allocated to receive sham wristbands].
“It’s not going to harm you in any way, just might
help you out, yes, oh yes I would recommend it to
anybody going through chemo because I am not sure
just how rough I would have felt having the chemo if
I didn’t have the bands.” [56 year old female receiving
high emetogenic chemotherapy, allocated to receive
true wristbands].
Discussion
This nested qualitative study aimed to explore cancer
patients’ experiences of using acupressure wristbands,
and taking part in a randomised controlled trial for a
CAM intervention. The two main motivators which pa-
tients identified for participating in the trial of acupres-
sure wristbands appear largely congruent with the
findings of previous research within the fields of cancer
and CAM. Nurgat et al. conducted a questionnaire sur-
vey to examine the motives of patients entering clinical
trials of novel cancer therapies and found that the two
main motivational factors influencing participation in a
clinical trial were a possible health benefit for the patient
themselves and to help future cancer patients [26]. How-
ever, of these the authors found patients appeared to be
primarily motivated by a personal health gain, a finding
which is consistent with other published research within
cancer [27,28]. These were again found to be the two
main motivators for patients participating in the trial of
acupressure wristbands. Contrary to previous work of
Nurgat and others [26-28], ‘giving something back’
appeared a stronger motivational factor than personal
health gain. Two nested qualitative studies have explored
the motivations of patients participating in clinical trials
of acupuncture. In the first patients’ felt acupuncture
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relief and to help with research for altruistic motives
[16]. While in the second study patients were found to
be primarily motivated by a sense of curiosity and for al-
truistic reasons, although a smaller number of patients
were identified as being motivated by a desire for symp-
tom relief [14].
Patients were largely satisfied with the organisation
and running of the acupressure wristband trial. The
process of recruitment was generally perceived as straight-
forward and had been adequately described. Interestingly,
a number of patients experienced positive outcomes as a
result of participating in the acupressure trial. These in-
cluded a sense of wellbeing from the altruistic act of
helping future cancer patients, as well as the process of
completing trial paperwork providing some control and a
means for patients to reflect on how their symptoms had
improved. This is a finding consistent with those of
previous research, with other studies reporting that trial
participants frequently perceive benefits from participat-
ing beyond any specific effects of the interventions admin-
istered, and including aspects of the participatory process
itself. These have included patients obtaining beneficial ef-
fects from helping others through participating in research
[29], and insights gained through completing trial diaries
of their symptoms [16]. A greater awareness and reporting
of these secondary beneficial outcomes for patients par-
ticipating in clinical trials could have positive implications
for recruitment to future clinical trials within cancer.
The primary outcome assessment for the clinical trial
of acupressure wristbands was level of nausea. Analysis
of the trial data revealed no statistically significant differ-
ences between the three groups (true wristbands, sham
wristbands, and no wristbands) [17]. However, the me-
dian nausea experience in patients using wristbands
(both real and sham) was somewhat lower than that in
the antiemetics only group [17]. The qualitative data
from the present study indicates that patients in both
the true and sham wristbands arms typically attributed
the wristbands as having had a positive impact on the
low levels of nausea and vomiting experienced during
the trial, with participants indicating they would recom-
mend the wristbands to other cancer patients receiving
chemotherapy. The quantitative and qualitative data sug-
gest that patients derive some benefit from using the
wristbands, irrespective of whether they are true or
sham. It has been suggested that CAM interventions
may be associated with eliciting enhanced placebo re-
sponses [30]. The findings from the present qualitative
study and clinical trial of acupressure wristbands would
appear to suggest that any benefit experienced by pa-
tients was likely to be the result of a placebo effect.
However there is considerable debate regarding the con-
ceptualisation of placebo effects. In particular whetherthe placebo effect should be viewed as a therapeutic
physiological response which could be studied and
harnessed to improve outcomes in patients [30-33]. It
has been argued that the placebo effect should even be
redefined as a ‘meaning response’ [34]. Certainly recent
qualitative research suggests that knowledge that the ef-
ficacy of CAM interventions could be based, to a greater
or lesser extent, on a placebo effect does not necessarily
undermine their appeal to patients [35].
Health service providers are placing increasing signifi-
cance on the experiences and preferences of patients. Pub-
lished research indicates that providing patient-centred,
tailored care can have a positive influence on various
health outcomes [36]. These include mortality [37], health
behaviour [38], treatment adherence [39], and self man-
agement [40]. Although the findings of our own trial
found acupressure to be ineffective for chemotherapy re-
lated nausea, some previously published trials have found
acupressure to be effective [41]. It would therefore appear
advisable that any future decisions relating to the health
service provision of acupressure wristbands include the
findings from qualitative research exploring patients’ ex-
periences in combination with all relevant economic and
clinical trial data.
Previous qualitative research exploring the experiences
of patients receiving treatment with acupuncture sug-
gests patients experience a range of benefits beyond the
alleviation of their presenting condition, including im-
provements in overall wellbeing, sleep pattern, and en-
ergy levels [1-6]. Many of the patients allocated to
receive wristbands who participated in interviews in the
present study perceived these wristbands, both true and
sham, as having a positive impact on the level of nausea
and vomiting they experienced. However, none of the
patients who participated in interviews associated the
acupressure wristbands as eliciting benefits beyond
the relief of chemotherapy related nausea and vomiting.
This may suggest that a greater stimulation of acupunc-
ture points is required to elicit these expanded effects;
or that the contextual factors within the acupuncture
consultation, such as the interaction between the practi-
tioner and patient, or the consultation setting, may work
in conjunction with the stimulation of acupuncture
points to elicit these expanded effects of care [42].
The findings from the present study have ramifications
for the validity of the findings of the acupressure wrist-
band trial [17], and more generally the future design of
clinical trials within the field of cancer. The data from
the present nested qualitative study revealed that two of
the nine patients receiving sham acupressure who were
interviewed had worn their wristbands inappropriately,
with both consequently receiving active treatments. The
study also revealed an apparent delay in some patients
completing the trial paperwork, relying on memory to
Hughes et al. BMC Complementary and Alternative Medicine 2013, 13:260 Page 9 of 10
http://www.biomedcentral.com/1472-6882/13/260complete outcome forms during the trial. Both of these
may represent confounding variables, which if generalis-
able to other patients in the acupressure wristband trial,
could have serious implications for the results of the
trial, and may be a factor in the trial finding the wrist-
bands to be ineffective [17]. Cancer and its conventional
treatment are associated with considerable symptoms
and a decline in physical function [43,44], and the find-
ings of the present study highlight the difficulties which
patients experience in completing trial outcome forms
during this period. It is therefore advisable that future
clinical trials consider this when designing their trial
protocol and select outcome assessments which will re-
duce the potential burden on patients and improve the
likelihood of patients completing the assessments on the
designated day(s).
It should be noted that as participants self-selected to
take part in qualitative interviews, this may represent a
potential limitation of the study. Specifically, it cannot
be ruled out that those patients who believed they had
benefited from using the acupuncture wristbands, both
real and sham, may have been more likely to agree to
participate in an interview exploring their experiences
than those patients who did not experience any benefit
from wearing the wristbands.Conclusions
Qualitative studies nested within clinical trials have been
underemployed within the field of CAM. The present
study demonstrates the potential value of qualitative re-
search of this nature. The fact some patients wore wrist-
bands inappropriately, and/or delayed completion of
trial paperwork are potentially serious threats to the val-
idity of the trial findings, and bring into question the
conclusions from this trial [17]. In addition the research
provides an insight into cancer patients’ motivations for,
and experiences of, taking part in a clinical trial for a
CAM intervention. This includes benefits to the patients
themselves from the participatory process of taking part
in the trial. In addition the research also represents the
first qualitative study to explore patients’ experiences of
using acupressure wristbands and perceptions of effects,
with patients’ perceiving the wristbands as reducing the
level of nausea and vomiting experienced during chemo-
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